IL6 and rheumatoid arthritis: Inflammatory cytokines including IL‐6 are known to contribute to the pathogenesis of rheumatoid arthritis, and monoclonal antibody such as tocilizumab is effective to some patients but not all rheumatoid arthritis with high remission rate.